Controversial US-backed vaccine trial in African newborns halted
Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn,…
We haven't written up this one. Guardian Health has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Controversial US-backed vaccine trial in African newborns halted theguardian.com
